Evidence map›Paper›PMID 26610428›Full record

ArticleScientific reports2015

pH-susceptibility of HLA-DO tunes DO/DM ratios to regulate HLA-DM catalytic activity.

Wei Jiang, Michael J Strohman, Sriram Somasundaram, Sashi Ayyangar, Tieying Hou, Nan Wang, Elizabeth D Mellins

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. A general platform for targeting MHC-II antigens via a single loop.bioRxiv : the preprint server for biology · 2024
    Article
  4. Tuning DO:DM Ratios Modulates MHC Class II Immunopeptidomes.Molecular & cellular proteomics : MCP · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. HLA-DO Modulates the Diversity of the MHC-II Self-peptidome.Molecular & cellular proteomics : MCP · 2019
    Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. The melting pot of the MHC II peptidome.Current opinion in immunology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Wei JiangDepartment of Pediatrics, Stanford University, Stanford, CA 94305, USA.
Michael J StrohmanDepartment of Pediatrics, Stanford University, Stanford, CA 94305, USA.
Sriram SomasundaramDepartment of Pediatrics, Stanford University, Stanford, CA 94305, USA.
Sashi AyyangarDepartment of Pediatrics, Stanford University, Stanford, CA 94305, USA.
Tieying HouDepartment of Pediatrics, Stanford University, Stanford, CA 94305, USA.
Nan WangDepartment of Pediatrics, Stanford University, Stanford, CA 94305, USA.
Elizabeth D MellinsDepartment of Pediatrics, Stanford University, Stanford, CA 94305, USA.
Stanford University · US

Funding

Spectrum Stanford Center for clinical and Translational Research and EducationUL1TR001085 · NCATS · STANFORD UNIVERSITY · PI CULLEN, MARK RICHARD, GREENBERG, HARRY BERNARD · 2013 to 2017
$37.1M
MOLECULAR &CELLULAR IMMUNOBIOLOGYT32AI007290 · NIAID · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Olivia M Martinez · 1985 to 2026
$27.0M
Stanford Center for Clinical and Translational Education and Research (SCCTER)UL1UL1RR025744 · NCRR · STANFORD UNIVERSITY · PI GREENBERG, HARRY BERNARD · 2008 to 2011
$22.4M
MHC association in autoimmune arthritisR21AI075253 · NIAID · STANFORD UNIVERSITY · PI MELLINS, ELIZABETH D · 2008 to 2010
$486k
Immunoglobulin as a novel ligand for HLA-DMR21AI095813 · NIAID · STANFORD UNIVERSITY · PI MELLINS, ELIZABETH D · 2011 to 2012
$435k
NCATS NIH HHS UL1 TR001085NCRR NIH HHS UL1 RR025744NIAID NIH HHS AI075253NIAID NIH HHS AI095813NIAID NIH HHS R21 AI075253NIAID NIH HHS R21 AI095813NIAID NIH HHS T32 AI007290NIAID NIH HHS T32 AI07290PHS HHS 1F32A1089080
6 · The paper itself

Abstract

The peptide-exchange catalyst, HLA-DM, and its inhibitor, HLA-DO control endosomal generation of peptide/class II major histocompatibility protein (MHC-II) complexes; these complexes traffic to the cell surface for inspection by CD4+ T cells. Some evidence suggests that pH influences DO regulation of DM function, but pH also affects the stability of polymorphic MHC-II proteins, spontaneous peptide loading, DM/MHC-II interactions and DM catalytic activity, imposing challenges on approaches to determine pH effects on DM-DO function and their mechanistic basis. Using optimized biochemical methods, we dissected pH-dependence of spontaneous and DM-DO-mediated class II peptide exchange and identified an MHC-II allele-independent relationship between pH, DO/DM ratio and efficient peptide exchange. We demonstrate that active, free DM is generated from DM-DO complexes at late endosomal/lysosomal pH due to irreversible, acid-promoted DO destruction rather than DO/DM molecular dissociation. Any soluble DM that remains in complex with DO stays inert. pH-exposure of DM-DO in cell lysates corroborates such a pH-regulated mechanism, suggesting acid-activated generation of functional DM in DO-expressing cells.

Indexed as

Antigen PresentationAmino Acid SequenceCatalytic DomainCD4-Positive T-LymphocytesDendritic CellsGene ExpressionHLA-D AntigensHumansHydrogen-Ion ConcentrationImmunoassayModels, MolecularMolecular Sequence DataPeptidesRecombinant ProteinsHLA-D AntigensHLA-DM antigensHLA-DO antigensPeptidesRecombinant Proteins

Identifiers

PMID26610428
PMCPMC4661524
OpenAlexW2410747818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.